| Name | Title | Contact Details |
|---|
Mississippi Blending Co. is a Keokuk, IA-based company in the Business Services sector.
Foreman Friedman is a full service litigation and business law firm that defines excellence in legal representation. The firm represents individuals, small businesses and some of the most widely recognized corporations in the world in a variety of legal matters. Our clients are international insurance companies, multi-national corporations, major cruise and shipping lines, and prominent businesses ranging from the traditional to the cutting edge. Our firm excels in providing dynamic legal representation, result oriented guidance, effective problem resolution, and global crisis management. Our team of legal professionals is experienced, responsive, and delivers excellence in and beyond the courtroom. You demand nothing less. You deserve nothing less.
Ludlow Enterprises is a Sanford, FL-based company in the Business Services sector.
The trucking industry is truly the backbone of the U.S. economy. Unfortunately, this critical industry has been largely underserved by modern software solutions, relying on dated technology and manual decision-making. Freight Science is bringing advanced data and analytics to enable large asset carriers to automate logistics and respond to rapidly changing market conditions.
CEPI – Coalition for Epidemic Preaparedness Innovations - is a new broad international coalition set up to fund development of vaccines against emerging infectious diseases with epidemic potential, where there are few market incentives. The epidemics like Ebola and SARS we have seen over the past years, have demonstrated the need for vaccines. Development of a vaccine takes many years, and it is too late to start when the outbreak has started. By having vaccines on the shelf ready for phase III early in an outbreak, we can demonstrate the vaccine efficacy and stop the outbreak while it is small. CEPI has already launched two calls for proposals; one for development of vaccines against MERS, Lassa and Nipah and one for the development of rapid response vaccine technology to enable development of vaccines against new and unknown diseases. CEPI was launched in January 2017 and now has funding totalling $620 million from soverign investors and philantropic institutions. CEPI`s investors are: The Governments of Australia, Belgium, Canada, Japan and Norway, as well as the Wellcome Trust and the Bill&Melinda Gates Foundation. In addition the European Commission will co fund activities with €250 million.